大麻非刑事化及医用许可后孕期使用大麻的伦理与管理：叙述性综述
The ethics and management of cannabis use in pregnancy following decriminalisation and licensing for medical use: narrative review.
作者信息
Towobola Abdulazeez, Towobola Basirat, Nair Bosky, Makwana Arti
机构信息
Kent and Medway NHS and Social Care Partnership Trust, Maidstone, Kent, UK.
East Sussex Healthcare NHS Trust, Hastings, East Sussex, UK.
出版信息
BJPsych Bull. 2023 Feb;47(1):28-37. doi: 10.1192/bjb.2021.102.
AIMS AND METHOD
As drug policies pertaining to cannabis use become more liberalised, the prevalence of cannabis use in pregnancy could increase. However, there is limited guidance available for clinicians. This paper presents a narrative review of literature published in the past 16 years (2006-2021) to (a) address the impact of legalisation and decriminalisation on the risks, ethics and support of women who use cannabis during pregnancy and (b) develop guidance for clinicians.
RESULTS
Both national and international trends suggest increased use of cannabis over the past decade, while the risks of cannabis use for recreational or medicinal purposes in pregnancy remain unmitigated.
CLINICAL IMPLICATIONS
This review confirmed that the recommendation of cannabinoid-based products for pregnant and breast-feeding women is currently premature. More research is needed to address safety concerns. We discussed navigating ethical concerns and suggest targeted management strategies for clinicians treating pregnant women who choose to use cannabis.
目的与方法
随着与大麻使用相关的药物政策日益宽松，孕期大麻使用的流行率可能会上升。然而，临床医生可获得的指导有限。本文对过去16年（2006 - 2021年）发表的文献进行了叙述性综述，以（a）探讨合法化和非刑事化对孕期使用大麻的女性的风险、伦理及支持方面的影响，以及（b）为临床医生制定指导意见。
结果
国内和国际趋势均表明，在过去十年中大麻使用有所增加，而孕期出于娱乐或药用目的使用大麻的风险依然未减。
临床意义
本综述证实，目前向孕妇和哺乳期妇女推荐基于大麻素的产品还为时过早。需要更多研究来解决安全问题。我们讨论了应对伦理问题的方法，并为治疗选择使用大麻的孕妇的临床医生提出了有针对性的管理策略。
Zotero 插件